Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The dry eye disease was worth US$ 6.1 billion in 2022. In 2031, it is predicted that the market will increase at a CAGR of 4.2%, reaching US$ 8.7 billion by the end of the forecast period. Pharmaceutical companies are likely to introduce new dry eye products and treatments.  The diagnosis and management of dry eye can be positively impacted by government initiatives designed to improve healthcare infrastructure and accessibility.

美国特拉华州威尔明顿，2024年1月4日（环球通讯社）——透明市场研究公司——2022年，干眼病价值61亿美元。2031年，预计市场将以4.2%的复合年增长率增长，到预测期结束时将达到87亿美元。制药公司可能会推出新的干眼症产品和治疗方法。旨在改善医疗保健基础设施和可及性的政府举措可以对干眼症的诊断和管理产生积极影响。

Eye care services may become more accessible as healthcare systems improve. Dry eye treatments may be available and approved based on the regulatory landscape. Researchers in DED are continuing to investigate the causes of the disease, which could improve treatment outcomes. Drugs, biologics, and gene therapies might be used to treat the disease in a specific way.

随着医疗保健系统的改进，眼科护理服务可能会变得更加容易获得。干眼症治疗可能是可用的，并根据监管情况批准。DED的研究人员正在继续调查这种疾病的原因，这可能会改善治疗效果。药物、生物制剂和基因疗法可能被用来以特定的方式治疗这种疾病。

Personalized treatments could be developed with more knowledge of dry eye etiology. Therapies tailored to a patient's individual characteristics and underlying causes could lead to better treatment outcomes. Request Sample PDF of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26096 Key Findings of the Market Report Based on product type, artificial tears are expected to contribute to the dry eye disease market.Hospital pharmacies will drive demand for dry eye disease medications.

随着对干眼症病因的更多了解，可以开发个性化治疗。针对患者的个体特征和根本原因量身定制的疗法可以带来更好的治疗效果。请求报告的PDF样本：https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26096市场报告的主要发现根据产品类型，人工泪液有望为干眼病市场做出贡献。医院药房将推动干眼症药物的需求。

North America held a dominant position in the global market in 2022.The increasing incidence of dry eye syndrome and the development of drugs that address the condition are driving the dry eye disease market size upward. Global Dry Eye Disease Market: Key Players Drug development is a priority for leading pharmaceutical companies, which are analyzing dry eye dis.

2022年，北美在全球市场上占据主导地位。干眼症发病率的增加以及解决这种疾病的药物的开发正在推动干眼症市场规模的扩大。全球干眼症市场：关键参与者药物开发是分析干眼症的领先制药公司的优先事项。